118. 36 months on treatment: Open-label phase I/II long-term study of enzyme replacement therapy (ERT) with “gene-activated” human glucocerebrosidase (GA-GCB) in patients with type I Gaucher disease

✍ Scribed by Ari Zimran; Kiran Bhirangi; Robert Mensah; Gheona Altarescu; Deborah Elstein

• Book ID: 116988303
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 45 KB
• Volume: 93
• Category: Article
• ISSN: 1096-7192
• DOI: 10.1016/j.ymgme.2007.10.130